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Abstract
Background: Rapid and accurate diagnosis and management can be lifesaving for patients with acute dyspnea.
However, making a differential diagnosis and selecting early treatment for patients with acute dyspnea in the
emergency setting is a clinical challenge that requires complex decision-making in order to achieve hemodynamic
balance, improve functional capacity, and decrease mortality. In the present study, we examined the screening
potential of rapid evaluation by lung-cardiac-inferior vena cava (LCI) integrated ultrasound for differentiating
acute heart failure syndromes (AHFS) from primary pulmonary disease in patients with acute dyspnea in the
emergency setting.
Methods: Between March 2011 and March 2012, 90 consecutive patients (45 women, 78.1 ± 9.9 years) admitted to
the emergency room of our hospital for acute dyspnea were enrolled. Within 30 minutes of admission, all patients
underwent conventional physical examination, rapid ultrasound (lung-cardiac-inferior vena cava [LCI] integrated
ultrasound) examination with a hand-held device, routine laboratory tests, measurement of brain natriuretic
peptide, and chest X-ray in the emergency room.
Results: The final diagnosis was acute dyspnea due to AHFS in 53 patients, acute dyspnea due to pulmonary
disease despite a history of heart failure in 18 patients, and acute dyspnea due to pulmonary disease in 19 patients.
Lung ultrasound alone showed a sensitivity, specificity, negative predictive value, and positive predictive value of
96.2, 54.0, 90.9, and 75.0%, respectively, for differentiating AHFS from pulmonary disease. On the other hand,
LCI integrated ultrasound had a sensitivity, specificity, negative predictive value, and positive predictive value of
94.3, 91.9, 91.9, and 94.3%, respectively.
Conclusions: Our study demonstrated that rapid evaluation by LCI integrated ultrasound is extremely accurate
for differentiating acute dyspnea due to AHFS from that caused by primary pulmonary disease in the
emergency setting.
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Introduction
Acute dyspnea is one of the main reasons for admission
to the emergency department (ED) [1]. Physicians work-
ing in the ED often need to make a rapid diagnosis and
devise a treatment plan on the basis of limited clinical
information [2,3]. In paticular, acute heart failue syn-
dromes (AHFS) are challenging, since the clinical, radio-
graphic, and laboratory parameters have variable
diagnostic value because AHFS are a heterogeneous set
of clinical syndromes [4]. Traditional diagnostic criteria
for heart failure are based on the history, physical exam-
ination, and chest radiograph findings [5-8]. However,
these criteria are often not very useful for ED patients
because of only having intermediate accuracy, i.e., high
specificity with lower sensitivity [9]. Bedside maneuvers
and tests that deliver rapid and reliable results represent
a cornerstone of ED diagnostics [1,2]. Recently, it was
reported that detection of pulmonary interstitial edema
by lung ultrasound evaluation of B-lines has a high diag-
nostic accuracy for differentiating cardiac-related
acute dyspnea from that due to chronic obstructive pul-
monary disease (COPD) or bronchial asthma in the ED
[3,10-14]. However, it can be very challenging to differ-
entiate AHFS from severe bilateral pneumonia, pulmon-
ary fibrosis, acute lung injury, or acute respiratory
distress syndrome (ARDS) by lung ultrasound alone, be-
cause B-lines are not specific for cardiogenic pulmonary
edema despite being a very sensitive indicator [12,13,15].
In order to rapidly and accurately identify the etiology in
patients with acute dyspnea, assessment of LV systolic
function, the severity of valvular regurgitation, and the
severity of volume overload is mandatory, not only to
confirm the diagnosis of AHFS but also to help deter-
mine the optimal initial treatment [2,16-21]. To assess
the severity of volume overload, it has been reported
that the right atrial pressure can be estimated by meas-
uring the diameter of the inferior vena cava (IVC) using
echocardiography [22-24]. Recently, Gargani suggested
that adding lung ultrasound to echocardiography (inte-
grated cardiopulmonary ultrasound) could help to differ-
entiate the main causes of acute dyspnea [13]. However,
the usefulness of integrated ultrasound evaluation of the
lungs, heart, and IVC for determining the etiology of
acute dyspnea in the ED has not been adequately studied
[25]. Therefore, we examined the screening potential
of rapid evaluation by lung-cardiac-inferior vena cava
(LCI) integrated ultrasound for differentiating AHFS




The study protocol was approved by our local ethics com-
mittee. From March 2011 to March 2012, 90 consecutive
patients admitted to the ED of our hospital with acute
dyspnea were enrolled. Patients with acute coronary syn-
drome or chest injury were excluded from this study. In
addition, patients who had acute dyspnea due to neither
cardiac nor pulmonary cause were excluded from this
study. Within 30 minutes of admission, all enrolled
patients received conventional physical examination, rapid
lung, cardiac, and inferior vena cava [IVC] ultrasound
with a hand-held device (VscanW), electrocardiography,
blood tests (including brain natriuretic peptide assay), and
chest X-ray in the emergency room. This study is being
conducted in accordance with the principles of the Declar-
ation of Helsinki. Written informed consent was obtained
from the patient for publication of this report and any ac-
companying images.
Rapid lung, cardiac, and IVC integrated ultrasound
The VscanW (GE Healthcare, Japan), a hand-held ultra-
sound device with a wide-bandwidth phased-array probe
(1.7-3.5 MHz), was used in this study [26,27]. The inves-
tigators were unaware of the chest X-ray findings and
clinical data of each patient. First, lung ultrasound was
performed. Bilateral scanning of the anterior and lateral
chest walls was done with the patient in the supine or
sitting position. The correct scan was intercostal with
maximum extension of the visual pleural line. The chest
wall was divided into 8 areas (2 anterior and 2 lateral
areas per side), and 1 scan was obtained for each area
[3,14,28-30]. The anterior zone of the chest wall was
designated from the sternum to the anterior axillary line
and then was divided into upper and lower halves (from
the clavicle to the third intercostal spaces and from the
third space to diaphragm). The lateral zone was posi-
tioned from the anterior axillary line to the posterior ax-
illary line and it was also divided into upper and lower
halves. The investigators attempted to detect comet tail
artifacts fanning out from the lung-wall interface and
spreading to the edge of the screen, which was previ-
ously named B-lines [14,28]. According to the definition
used in previous reports, lung ultrasound examination is
positive if B-lines are found in two or more zones bilat-
erally of the eight zones assessed [3,28-30]. Lung ultra-
sound examination was always completed within 1 minute.
Subsequently, cardiac ultrasound was performed. Global
LV systolic function and the severity of mitral or tricuspid
regurgitation were estimated visually from images acquired
in standard cardiac views, particularly the apical long-axis
view combined with the four-chamber view [16,17,25,31].
Preservation of the LV ejection fraction (EF) was defined as
an estimated LVEF ≥40%, whereas a LVEF <40% indicated
a reduced EF. Color scanning was also performed to assess
flow across the mitral and tricuspid valves. Valvular regur-
gitation was semi-quantitatively assessed on a five-grade
scale (none, trivial, mild, moderate, or severe), based on
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the width of the regurgitant jet at its origin esti-
mated by visual inspection. A positive cardiac ultra-
sound examination meant that either a presence of
moderate to severe mitral regurgitation (MR) in pre-
served EF subjects or a presence of moderate to se-
vere MR or tricuspid regurgitation (TR) in reduced
EF subjects was detected [19-21,32-34]. Finally, ultrasound
evaluation of the IVC was examined within 2.0 cm of the
IVC-RA junction. The maximum diameter (IVC max) was
measured at the end-expiration and minimum diameter
(IVC min) was measured at the end-inspiration [35]. The
IVC collapsibility index (IVC-CI) was calculated as (IVC
max-IVC min)/IVC max [35,36]. A positive IVC ultra-
sound examination, according to the definition in previous
reports, required an IVC-CI <50% at baseline [23,24,35,37].
The duration of LCI-integrated ultrasound examination
was always less than 3 minutes (Figure 1) [14]. The images
of lung-cardiac-IVC integrated ultrasound were shown in
Figure 2.
Assay of brain natriuretic peptide (BNP)
Peripheral venous blood samples were obtained from each
patient at admission, and then 5 ml of whole blood was
placed into a prechilled vacuum tube containing EDTA
for subsequent measurement of BNP. Immediately after
blood sampling, each tube was placed on ice and centri-
fuged at 2,500 rpm and 4°C to obtain plasma. Then the
plasma BNP level was measured by immunoradiometric
assay using an antibody for human BNP (Shionogi Co.
Ltd., Tokyo, Japan).
Confirmation of diagnosis
The initial diagnosis was determined for each patient by
one or two cardiologists, who performed lung-cardiac-IVC
(LCI) integrated ultrasound evaluation within 3 minutes
on each patient in the ED. Confirmation that acute dys-
pnea was due to a cardiac etiology (AHFS) was based on a
positive lung ultrasound examination combined with ab-
normal findings on either cardiac or IVC ultrasound in
the ED (Figure 1). To determine the final diagnosis, two
cardiologists and one pneumologist, who were blinded to
the results of the LCI integrated ultrasound at admission,
independently reviewed each patient’s medical records
and classified them as having acute dyspnea due to AHFS,
a history of HF but acute dyspnea due to a non-cardiac
cause, or non-cardiac acute dyspnea. Confirmation of
AHFS was based on the generally accepted Framingham
criteria (two major criteria or one major and two minor
criteria), with corroborative information including the
medical history, hospital course (response to diuretics and
vasoactive agents, or results of hemodynamic monitoring),
and routine laboratory test data (including BNP) [5,38].
The category of pulmonary acute dyspnea included pul-
monary embolism and primary lung diseases (pneumonia,
asthma, COPD, pulmonary fibrosis, or acute respiratory
distress syndrome), with or without underlying LV systolic
Diffuse multiple bilateral
B-lines
- Pulmonary edema of various causes
- Interstitial pneumonia/pneumonitis
- Pulmonary fibrosis
- Acute respiratory distress syndrome (ARDS)
Cardiac ultrasound
MR or TR:
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Figure 1 Algorithm for the diagnosis of acute dyspnea based on the lung-cardiac-inferior vena cava integrated ultrasound. LVEF = left
ventricular ejection fraction; MR =mitral regurgitation; TR = tricuspid regurgitation; IVC = inferior vena cava.
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dysfunction but with no evidence of decompensated HF at
admission.
Statistical analysis
Analyses were performed with SAS 9.1 software (SAS
Institute, Cary, North Carolina). Quantitative variables
were compared by using Student’s t-test, and dichotom-
ous variables were compared with the chi-square test.
The area under the receiver operating characteristic
curves and the Youden index were calculated to define
the optimum cut-off value of BNP for differentiating
AHFS from pulmonary disease. The sensitivity, specifi-
city, negative predictive value, and positive predictive
value were calculated according to standard definitions.
Two-tailed P values of less than 0.05 were considered to
indicate a statistically significant difference. All analyses
were performed by an independent biostatistics center
(Statz Institute, Inc., Tokyo, Japan).
Results
Among 90 consecutive patients with acute dyspnea
(45 females, 78.1 ± 9.9 years), the final diagnosis was
acute dyspnea due to AHFS in 53 patients, acute dys-
pnea due to a pulmonary cause despite a history of heart
failure in 18 patients, and acute dyspnea due to a pul-
monary cause in 19 patients. Cardiogenic acute dyspnea
(AHFS) was due to ischemic heart disease, hypertensive
heart disease, valvular heart disease, and idiopathic
dilated cardiomyopathy in 10, 29, 6, and 8 patients, re-
spectively. Non-cardiogenic acute dyspnea was due to
asthma or COPD, pneumonia, pulmonary fibrosis, and
ARDS in 16, 9, 7, and 5 patients, respectively. The main
clinical characteristics of the patients stratified according
to their final diagnoses are shown in Table 1. When
patients with AHFS-related acute dyspnea were compared
to those with pulmonary-related acute dyspnea, both
groups were of a similar age and had a similar rate of prior
hospitalization for HF, but a history of hypertension was
more common in the AHFS group. The plasma BNP level
was significantly higher in the AHFS group than in the
pulmonary group. On the other hand, C-reactive protein
was significantly higher in the pulmonary group than in
the AHFS group.
Relation between plasma BNP and final diagnosis
Patients with acute dyspnea due to AHFS had a BNP level
of 622.0 ± 505.3 pg/ml, which was significantly higher than
the BNP level of 230.7 ± 208.2 pg/ml in patients with a
(A) (B) (C)
Figure 2 Imaging of lung-cardiac-inferior vena cava (LCI) integrated ultrasound. (A) Imaging of the lung ultrasound: Alines (upper)
and B-lines (lower). (B) Imaging of the cardiac ultrasound: Apical long-axis view (upper) and moderate mitral regurgitation (lower). (C) Imaging of
the inferior vena cava ultrasound: Collapsibility ≥ 50% (upper) and < 50% (lower).
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final diagnosis of pulmonary disease (p < 0.001). In the
group with acute dyspnea due to pulmonary disease, the
18 patients with a history of heart failure had a signifi-
cantly higher BNP level compared to the 19 patients with-
out a history of heart failure (396.7 ± 176.5 vs. 73.4 ±
59.6 pg/ml, p < 0.001). The BNP level of patients with a
history of heart failure and dyspnea due to pulmonary dis-
ease showed no significant difference from that of the
patients with acute dyspnea due to AHFS (396.7 ± 176.5
vs. 622.0 ± 505.3 pg/ml; p = 0.069). In addition, the BNP
level of patients with ARDS (n = 5) showed no significant
difference from that of patients with acute dyspnea due to
AHFS (369.5 ± 246.3 vs. 622.0 ± 505.3 pg/ml; p = 0.277).
The ability of BNP to differentiate AHFS from pulmonary
disease was assessed by ROC analysis. The area under
the ROC curve for differentiating AHFS from pulmonary
disease with BNP was 0.750 (95% confidence interval:
0.698 to 0.804). A BNP value of 663.2 pg/ml had a sensi-
tivity of 37.0%, specificity of 97.2%, negative predictive
value of 50.7%, and positive predictive value of 95.2% for
differentiating AHFS from pulmonary disease.
Lung-cardiac-inferior vena cava (LCI) integrated
ultrasound
In Table 2, the sensitivity, specificity, negative predictive
value (PV), positive PV, and total accuracy for differentiating
AHFS from pulmonary disease in emergency patients with
acute dyspnea are presented for Framigham criteria (two
major or one major and two minor criteria), BNP (cut-off
value: 100 pg/mL), lung ultrasound, both lung ultrasound
and BNP (cut-off value: 100 pg/mL), IVC collapsibility
(cut-off value: 50%), either MR or TR (≥ moderate), both
preserved EF and MR (≥ moderate), both reduced EF and
either MR or TR (≥ moderate), and LCI integrated ultra-
sound. Comparing these methods showed that LCI inte-
grated ultrasound had the highest specificity (91.9%),
negative PV (91.9%), positive PV (94.3%), and total
Table 1 Baseline characteristics in overall patients and











Mean age, yrs 78.1 ± 9.9 77.7 ± 10.3 78.6 ± 9.2 0.662





42 (46.7) 27 (50.9) 15 (40.5) 0.330
Hypertension 51 (56.7) 38 (71.7) 13 (35.1) <0.001
Dyslipidemia 20 (22.2) 16 (30.2) 4 (10.8) 0.029





24 (26.7) 13 (24.5) 11 (29.7) 0.583
History of atrial
fibrillation
22 (24.4) 12 (22.6) 10 (27.0) 0.634
Medications prior to admission
Loop diuretic 47 (52.2) 31 (58.5) 16 (43.2) 0.154
Spironolactone
or Eplerenone
31 (34.4) 22 (41.5) 9 (24.3) 0.091
ACE inhibitor
or ARB
45 (50.0) 33 (62.3) 12 (32.4) 0.005
Beta-blocker 27 (30.0) 17 (32.1) 10 (27.0) 0.607
Calcium
channel blocker
13 (14.4) 9 (16.9) 4 (10.8) 0.413












1.07 ± 0.51 1.12 ± 0.58 0.99 ± 0.36 0.203
C-reactive
protein, mg/dl
3.64 ± 5.73 1.96 ± 3.17 6.05 ± 7.52 <0.001
Symptoms on admission




40 (44.4) 28 (52.8) 12 (32.4) 0.055
Peripheral
edema
48 (53.3) 37 (69.8) 11 (29.7) <0.001
Signs on admission
Rales 56 (62.2) 37 (69.8) 19 (51.3) 0.075
Wheezing 38 (42.2) 20 (37.7) 18 (48.6) 0.302
Jugular venous
distension
25 (27.8) 19 (35.8) 6 (16.2) 0.041
S3 19 (21.1) 15 (28.3) 4 (10.5) 0.045
Table 1 Baseline characteristics in overall patients and
according to final diagnosis (Continued)
Ultrasound findings
Pleural effusion 18 (20.0) 14 (26.4) 4 (10.5) 0.069
Lung
consolidation
10 (11.1) 1 (1.9) 9 (24.3) <0.001
Reduced EF
(LVEF <40%)
22 (24.4) 16 (17.8) 6 (16.2) 0.129
MR≥moderate 41 (45.6) 41 (77.3) 0 ( 0.0) <0.001
TR≥moderate 38 (42.2) 34 (64.5) 4 (10.5) <0.001
IVC collapsibility
<50%
51 (56.7) 44 (83.0) 7 (18.9) <0.001
Values are shown as the no. (%), mean ± SD. AHFS = acute heart failure
syndromes; ACE = angiotensin-converting enzyme; ARB = angiotensin receptor
blocker. LV = left ventricular; EF = ejection fraction; MR =mitral reguragitation;
TR = tricuspid regurgitation; IVC = inferior vena cava.
Kajimoto et al. Cardiovascular Ultrasound 2012, 10:49 Page 5 of 8
http://www.cardiovascularultrasound.com/content/10/1/49
accuracy (93.3%). While lung ultrasound alone had the
highest sensitivity (96.2%), its specificity was much lower
(54.0%). A reduced EF showed the lowest sensitivity and
lowest total accuracy (26.4% and 51.1%, respectively),
while BNP at a cut-off value of 100 pg/mL had the lowest
specificity (35.1%).
Discussion
The present study demonstrated that rapid evaluation by
lung-cardiac-inferior vena cava (LCI) integrated ultra-
sound has a higher diagnostic accuracy for differentiat-
ing acute dyspnea due to AHFS from pulmonary acute
dyspnea (including COPD/asthma, pulmonary fibrosis,
and ARDS) compared with lung ultrasound either alone
or in combination with plasma BNP assay. These find-
ings suggest that LCI integrated ultrasound has become
a fundamental tool for diagnostic evaluation of patients
with acute dyspnea and selection of early treatment in
the emergency setting.
Rapid and accurate diagnosis and management can be
lifesaving for patients with acute dyspnea [39]. However,
making a differential diagnosis and selecting early treat-
ment for patients with acute dyspnea in the ED is a
clinical challenge that requires complex decision-making
in order to achieve hemodynamic balance, improve func-
tional capacity, and decrease mortality and the length of
hospital stay [40]. Methods for evaluation of emergency
patients with possible AHFS include the history, physical
examination, chest radiography, 12-lead electrocardiog-
raphy, and measurement of BNP or N-terminal pro-BNP
[5-10]. Among these methods, chest radiography is a
cornerstone in the diagnostic evaluation of acute dys-
pnea. Although chest radiography serves a vital role in
the evaluation of patients with acute dyspnea, including
the identification of various causes, the lack of radio-
graphic signs of congestion does not exclude AHFS
[2,41]. Recently, BNP and N-terminal pro-BNP have
been studied extensively and are frequently used in clin-
ical practice. However, some recent randomized trials on
the use of BNP to aid in diagnosis or serial BNP levels
to dictate therapy in the acute setting found no improve-
ment of diagnostic accuracy or important clinical out-
comes because age, sex, and renal dysfunction have an
impact on natriuretic peptide levels and need to be con-
sidered when test results are interpreted [42,43]. Also,
patients with a history of decompensated HF can have
chronically elevated BNP or N-terminal pro-BNP levels,
making the test inconclusive. In addition, it was reported
that BNP does not reliably distinguish ARDS from AHFS
[44]. In our study, the BNP level of patients with a his-
tory of heart failure who had dyspnea due to pulmonary
disease or ARDS showed no significant difference com-
pared to that of patients with acute dyspnea due to
AHFS, a finding that is in agreement with prior reports
[42,43]. Therefore, among patients with acute dyspnea
(including those with a history of heart failure and those
with ARDS), the baseline BNP level alone could have
various limitations for making a differential diagnosis in
the emergency setting, and further research is needed to
address this issue.
B-lines assessed by lung ultrasound have been proposed
as an easy alternative diagnostic tool for monitoring pul-
monary congestion in AHFS patients [28]. Recently, it
was reported that B-lines alone or B-lines combined with
N-terminal pro-BNP show a high diagnostic accuracy for
differentiating AHFS-related acute dyspnea from that due
to COPD/asthma in the ED [3,41]. However, it is impossible
to differentiate AHFS from bilateral pneumonia, pulmonary
fibrosis, or ARDS by lung ultrasound alone, because al-
though B-lines are a very sensitive sign of cardiogenic pul-
monary edema, this sign is not specific [13]. However, in
the present study, the lung ultrasound in two patients with
pure right-sided heart failure, which was not in association
with left-sided heart failure, showed a false negative, sug-
gesting that B-lines may not be sensitive for pure right-
sided heart failure. Recently, Gargani has suggested that
addition of lung ultrasound to echocardiography provides
Table 2 Plasma BNP, lung ultrasound alone or combined
with BNP, cardiac findings, and the LCI integrated











BNP ≥100 pg/ml 92.4 35.1 76.4 67.1 68.8
Framingham
criteria*
79.2 56.7 65.6 64.6 70.0
Lung ultrasound
alone




88.6 67.6 80.6 79.8 80.0
Reduced EF
(LVEF <40%)
26.4 86.5 45.1 73.7 51.1
MR or TR ≥
moderate
92.4 81.0 88.2 87.5 87.7
IVC collapsibility
<50%
83.0 81.1 76.9 86.3 82.2
Both preserved EF
and MR ≥moderate
56.7 100.0 61.6 100.0 67.0
Both reduced EF
and either MR or
TR ≥moderate





94.3 91.9 91.9 94.3 93.3
* Two major or one major and two minor criteria. BNP = brain natriuretic
peptide; LCI = lung-cardiac-inferior vena cava; AHFS = acute heart failure
syndromes; NPV = negative predictive value; PPV = positive predictive value;
LVEF = left ventricular ejection fraction; IVC = inferior vena cava; MR =mitral
regurgitation; TR = tricuspid regurgitation.
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additive information about pulmonary involvement [13].
Furthermore, Kimura et al. has reported the usefulness of
cardiopulmonary-limited ultrasound examination consist-
ing of only 4 ultrasound views, such as LV systolic dys-
function, left atrial enlargement, IVC, and B-lines, for the
diagnostic accuracy and prognostic information, although
they did not evaluate a diagnostic accuracy for differentiat-
ing acute dyspnea due to AHFS from that caused be pri-
mary pulmonary disease [45]. On the basis of these
available reports and our findings, it is suggested that LCI
integrated ultrasound assists with the rapid and accurate
diagnosis and treatment of acute dyspnea in the emer-
gency setting.
Our study had several limitations. First, this was a
single-center investigation of a small patient population.
Second, assessment of diastolic dysfunction and quantita-
tive analysis of valvular heart disease could not be done
with the hand-held ultrasound device employed in this
study. Therefore, complete evaluation of acute dyspnea in
patients requires comprehensive standard echocardiog-
raphy after LCI ultrasound evaluation. Third, we could
not evaluate the extravascular lung water in AHFS
patients because we did not examine the number of B-
lines. Therefore, further prospective investigation to evalu-
ate the extravascular lung water by a hand-held device for
patients with acute dyspnea in the emergency setting is
needed. Fourth, training is needed to interpret the findings
of LCI ultrasound.
In conclusion, our study demonstrated that rapid evalu-
ation by lung-cardiac-IVC (LCI) integrated ultrasound has
a higher accuracy for differentiating AHFS-related acute
dyspnea from pulmonary-related acute dyspnea compared
with lung ultrasound alone or lung ultrasound combined
with BNP. These findings suggest that LCI integrated
ultrasound is a useful tool to expedite the evaluation of
patients with acute dyspnea before initiating treatment in
the ED. However, further research will be needed to pro-
vide more insight into the impact of LCI integrated ultra-
sound using a portable ultrasound device on diagnosis
and decision making in the ED.
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